ArticleScientific reports2017

Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.

Joanne M Donkers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.